← Open Payments lookup

LETICIA COOPER: Open Payments

NPI 1841826724 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,348 in 62 payments from 16 companies in 2025. Trend: 2023 $1,398 · 2024 $857 · 2025 $1,348

Food & beverage: $1,348
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.14$224
Calliditas Therapeutics US Inc.6$183
Otsuka America Pharmaceutical, Inc.8$178
Amgen Inc.6$161
Boehringer Ingelheim Pharmaceuticals, Inc.7$137
Novo Nordisk Inc4$100
AstraZeneca Pharmaceuticals LP3$65
OPKO Pharmaceuticals, LLC3$58
Takeda Pharmaceuticals U.S.A., Inc.2$47
ANI Pharmaceuticals, Inc.2$46

Products named: Kerendia, TARPEYO, JYNARQUE, TAVNEOS, JARDIANCE, Ozempic, RAYALDEE, GATTEX.

Industry payments across TX — which companies pay providers there.